• Central Pathways in Opioid-Induced Mechanical Hypersensitivi

  2026-08-05

  This study uncovers a specific brain-to-spinal opioid circuit underlying morphine-induced mechanical hypersensitivity and analgesic tolerance in mice. By precisely mapping the lPBNMOR–PVHDyn–SDHKOR-GABA pathway, it provides foundational insight into the mechanisms driving opioid-induced pain sensitization, with implications for refining neuropharmacologic research models.

• Ivermectin: Benchmarks and Best Practices in Anti-Parasitic

  2026-08-05

  Ivermectin is a validated broad-spectrum anti-parasitic agent used in both clinical and experimental settings. This dossier clarifies its mechanism, practical parameters, and quality standards, providing a reference for anti-parasitic research compound deployment.

• SB 431542: ALK5 Inhibitor Workflows for TGF-β Pathway Contro

  2026-08-04

  SB 431542, a potent and selective ALK5 inhibitor, empowers researchers to dissect TGF-β signaling with precision in stem cell differentiation, cancer immunology, and organoid modeling. This article translates recent advances—including hiPSC-derived hepatobiliary organoid generation and anti-tumor immune modulation—into actionable protocols, troubleshooting insights, and comparative workflow advantages for cell-based assays.

• Tigecycline (SKU A5226): Reliable Workflows for MDR Bacteria

  2026-08-04

  This article addresses real-world laboratory challenges in multidrug-resistant (MDR) bacteria research and demonstrates how Tigecycline (SKU A5226) optimizes experimental reliability. With a scenario-driven approach, it offers evidence-based guidance on protocol design, data interpretation, and product selection—highlighting APExBIO's validated Tigecycline for advanced cell-based assays.

• Acetylspiramycin in Translational Antimicrobial Resistance R

  2026-08-03

  This thought-leadership article explores how Acetylspiramycin (Spiramycin B) is redefining translational research at the intersection of antimicrobial resistance, ribosomal targeting, and immune modulation. It offers mechanistic insights, strategic workflows, and evidence-backed guidance for researchers seeking to address rising macrolide resistance, especially in challenging pathogens. The discussion advances beyond standard product overviews, integrating clinical surveillance data, competitive strain engineering, and actionable protocol recommendations, while positioning APExBIO's Acetylspiramycin as a pivotal tool for cutting-edge studies.

• Targeting ERK/MMP1 to Inhibit HCC Metastasis: Insights from

  2026-08-03

  The referenced study reveals that Praeruptorin A suppresses human hepatocellular carcinoma (HCC) cell metastasis by targeting the ERK/MMP1 signaling axis, without inducing cytotoxicity or altering cell cycle progression. These findings highlight the ERK/MMP1 pathway as a promising target for developing novel hepatoprotective agents and improve understanding of metastasis regulation in liver disease research.

• Gasdermin C Drives Stemness and Immune Evasion in PDAC

  2026-08-02

  This study uncovers a pyroptosis-independent role for Gasdermin C (GSDMC) in promoting stemness and immune evasion in pancreatic ductal adenocarcinoma (PDAC). By elucidating the nuclear functions of GSDMC and its regulation via ADAM17-mediated cleavage, the research identifies new therapeutic targets to enhance treatment responses in aggressive pancreatic cancer.

• Ivermectin: Broad-Spectrum Anti-Parasitic in Translational R

  2026-08-01

  Ivermectin’s high-purity, FDA-approved formulation empowers precise anti-parasitic and tumor microenvironment studies. This article delivers actionable workflows, advanced troubleshooting, and cross-domain insights, highlighting how APExBIO’s Ivermectin supports evolving oncology and parasitology research.

• Connexin 43/NF-κB Pathway in AngII-Induced Macrophage Polari

  2026-07-31

  This study elucidates how angiotensin II (AngII) promotes RAW264.7 macrophage polarization to the pro-inflammatory M1 phenotype via the connexin 43 (Cx43)/NF-κB signaling axis. The findings highlight Cx43 hemichannels as viable targets for modulating macrophage-driven inflammation relevant to cardiovascular and neuroinflammatory research.

• Sulfo-Cy3 Azide in Developmental Neurogenetics: Precision La

  2026-07-31

  Explore how Sulfo-Cy3 azide empowers advanced bioconjugation and fluorescent labeling in neurodevelopmental assays. This article reveals unique, assay-critical insights for mapping Nurr1+ neuron development, advancing beyond current content.

• Applied Workflows with Recombinant Human IL-15 in Immunology

  2026-07-30

  Recombinant Human IL-15 (E.coli, Tag Free, Lyophilized) offers robust, reproducible activation of T and NK cells, empowering both standard and translational neuroimmune models. This guide delivers actionable protocols, troubleshooting strategies, and bridges cutting-edge neuroscience with immune modulation for next-generation experimental design.

• Drosophila Keap1 Nuclear Condensates in Oxidative Stress Res

  2026-07-30

  This study uncovers how Drosophila Keap1 (dKeap1) proteins assemble nuclear condensates in response to oxidative stress, revealing a previously uncharacterized mechanism for Keap1 function beyond cytoplasmic Nrf2 regulation. The discovery of intrinsically disordered domains mediating condensate formation broadens our understanding of the Keap1-Nrf2 pathway’s nuclear roles in stress adaptation and development.

• Amikacin Sulfate Workflows: Precision Delivery for NTM Infec

  2026-07-29

  Amikacin Sulfate empowers researchers to target stubborn intracellular pathogens, notably Mycobacterium avium, with superior efficacy and minimal toxicity. This guide unpacks advanced in vitro and in vivo workflows, troubleshooting strategies, and emerging delivery paradigms that set APExBIO’s product apart for infectious disease modeling.

• 3-Methyladenine: Precision Autophagy Inhibition in Cell Mode

  2026-07-29

  3-Methyladenine (3-MA) enables selective, temporal inhibition of autophagy, empowering researchers to dissect the PI3K signaling pathway in both cancer and neurobiology models. This guide translates cutting-edge evidence into actionable protocols, troubleshooting tips, and comparative insights that maximize the scientific yield of APExBIO’s 3-MA.

• Clozapine in Schizophrenia Research: Pathways, Protocols, an

  2026-07-28

  Explore the multifaceted applications of Clozapine as an atypical antipsychotic medication in schizophrenia research. This in-depth article uncovers novel signaling pathways, protocol insights, and emerging translational strategies, distinguishing itself with practical guidance for advanced experimental design.

453 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page